Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine). Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease. 558

Member's Comments

No comment yet.

Related content which might interest you: “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Airway infection in COPD Year: 2019 Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Expression and function of IL-20 cytokines and their receptors on the airway epithelium during Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand? Source: International Congress 2018 – COPD management Year: 2018 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020